Glycoprotein 88 (GP-88) serum levels as a marker of response to therapy in patients with metastatic breast cancer

被引：0
|
作者：
Tkaczuk, Katherine H. R.
Rosenbatt, Paula
Sulkowski, Sarah
Tait, Nancy
Yue, Binbin
Serrero, Ginette
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
PROGRANULIN; SURVIVAL;
D O I：
10.1158/1538-7445.SABCS21-OT1-05-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-05-01
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
    Greither, Thomas
    Fischer, Kersten
    Theil, Gerit
    Marcou, Marios
    Holzhausen, Hans-Juergen
    Weigelt, Katrin
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Fornara, Paolo
    Wullich, Bernd
    Taubert, Helge
    Wach, Sven
    Lieb, Verena
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4173 - 4180
  • [22] Comparison of serum HER-2/neu levels and clinical response in metastatic breast cancer patients on Herceptin therapy.
    Kish, LA
    Goldblatt, J
    Neaman, I
    Levine, R
    Ghani, F
    Armstrong, G
    CLINICAL CHEMISTRY, 2001, 47 (06) : A132 - A132
  • [23] SERUM GLYCOPROTEIN ELECTROPHORESIS IN PATIENTS WITH METASTATIC CANCER
    SILVERMAN, LM
    DERMER, GB
    MARTIN, G
    TOKES, ZA
    CLINICAL CHEMISTRY, 1978, 24 (06) : 1003 - 1003
  • [24] USE OF SERUM GLYCOPROTEIN LEVELS IN EVALUATING CANCER PATIENTS AFTER THERAPY
    SHETLAR, MR
    SHETLAR, CL
    CANCER RESEARCH, 1955, 2 (01) : 45 - 46
  • [25] Progranulin (GP88) is an independent prognostic factor for prostate cancer patients
    Taubert, Helge W.
    Abdulrahman, Amer
    Eckstein, Markus
    Jung, Rudolf
    Guzman, Juan
    Weigelt, Katrin
    Serrero, Ginette
    Yue, Binbin
    Geppert, Carol
    Stoehr, Robert
    Hartmann, Arndt
    Wullich, Bernd
    Wach, Sven
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Role of PCDGF/GP88 in the proliferation and herceptin response of Her-2 overexpressing breast cancer cells
    Kim, Wes
    Serrero, Ginette
    CANCER RESEARCH, 2006, 66 (08)
  • [27] SERUM OSTEOCALCIN LEVELS IN PATIENTS WITH PRIMARY AND METASTATIC BREAST-CANCER
    GOERNER, R
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 793 - 796
  • [28] Glycoprotein components in the serum of patients with cancer breast
    Varkey M.
    Devi R.S.
    Rao S.B.
    Indian Journal of Clinical Biochemistry, 1997, 12 (1) : 63 - 66
  • [29] On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy
    Tkaczuk, Katherine
    Rosenblatt, Paula
    Mehra, Ranee
    Scilla, Katherine
    Tait, Nancy
    Yue, Binbin
    Serrero, Ginette
    CANCER RESEARCH, 2024, 84 (09)
  • [30] Serum EGFR and HER-2 levels in metastatic breast cancer patients receiving gefitinib therapy.
    Allen, C. L.
    Chapman, C. J.
    Hitch, A.
    Agrawal, A.
    Cheung, K. L.
    Robertson, J. F. R.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S91 - S92
12345